Disease progression in melanoma patients with negative sentinel lymph node: Does false-negative specimens entirely account for this phenomenon?

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 2, 2012, Pages 242-248

  Savoia, P ^a   Fava, P ^a   Caliendo, V ^b   Osella Abate, S ^a   Ribero, S ^b   Quaglino, P ^a   MacRipo G ^b   Bernengo, M G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FALSE NEGATIVE RESULT; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MELANOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SEX DIFFERENCE; SKIN METASTASIS; TUMOR GROWTH; VISCERAL METASTASIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY; YOUNG ADULT;

EID: 84856350465     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04055.x     Document Type: Article

References (30)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
2. Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histological negative sentinel lymph nodes. Arch Surg 1999; 134: 381-387. (Pubitemid 29282079)
3. Scolyer RA, Thompson JF, Li LXL, et al. Failure to remove true sentinel nodes can cause failure of the sentinel node biopsy technique: evidence from antimony concentrations in false negative sentinel nodes from melanoma patients. Ann Surg Oncol 2004; 11 (3 Suppl): 174S-178S.
4. Zogakis TG, Essner R, Wang H, et al. Melanoma recurrence patterns after negative sentinel lymphadenectomy. Arch Surg 2005; 140: 865-872. (Pubitemid 41345983)
5. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
6. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, et al. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol 2006; 13: 1655-1663. (Pubitemid 44951474)
7. Lam TK, Uren RF, Scolyer RA, et al. False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy. Melanoma Res 2009; 19: 94-99.
8. Nieweg OE,. False-negative sentinel node biopsy. Ann Surg Oncol 2009; 16: 2089-2091.
9. Kelly JW, Sagebiel RW, Calderon W, et al. The frequency of local recurrence and microsatellites as a guide to reexcision of margins for cutaneous malignant melanoma. Ann Surg 1984; 200: 759-763. (Pubitemid 15216759)
10. Bernengo MG, Doveil GC, Lisa F, et al. [Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)]. G Ital Dermatol Venereol 1986; 121: 311-326.
11. Bernengo MG, Quaglino P, Cappello N, et al. Time course and pattern of first relapse in stage I-II primary cutaneous melanoma: a multivariate analysis of disease-free survival in 3,174 patients followed-up at the Turin Melanoma Centre from 1975 to 2004. G Ital Dermatol Venereol 2005; 140: 191-200. (Pubitemid 43951247)
12. Garbe C, Hauschild A, Volkenandt M, et al. Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res 2008; 18: 61-67. (Pubitemid 351628058)
13. Quaglino P, Borgognoni L, Bottoni U, et al. Italian guidelines for staging and follow-up of stage I-II cutaneous melanoma patients. G Ital Dermatol Venereol 2007; 142: 41-47. (Pubitemid 46607142)
14. Cook MG, Di Palma S,. Pathology of sentinel lymph nodes for melanoma. J Clin Pathol 2008; 6: 897-902.
15. Kaplan EL, Meier P,. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 475-480.
16. Mantel N,. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
17. Carlson GW, Page AJ, Cohen C, et al. Regional recurrence after negative sentinel lymph node biopsy for melanoma. Ann Surg 2008; 248: 378-386.
18. Francischetto T, Spector N, Neto Rezende JF, et al. Influence of sentinel lymph node tumour burden on survival in melanoma. Ann Surg Oncol 2010; 17: 1152-1158.
19. Mattsson J, Bergkvist L, Abdiu A, et al. Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005. Acta Oncol 2008; 47: 1519-1525.
20. Bryan J, Nieweg OE,. New boundaries for lymphatic mapping-report of the Fifth International Sentinel Node Conference. Melanoma Res 2007; 17: 261-263. (Pubitemid 47067087)
21. Quaglino P, Marenco F, Osella-Abate S, et al. Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study. Ann Oncol 2010; 21: 409-414.
22. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000; 7: 469-474. (Pubitemid 30439307)
23. Gershenwald JE, Tseng CH, Thompson W, et al. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery 1998; 124: 203-210. (Pubitemid 28372917)
24. Jacobs IA, Chevinsky AH, Swayne LC, et al. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: reliability of the procedure and analysis of failures after long-term follow-up. J Surg Oncol 2001; 77: 157-164. (Pubitemid 32645769)
25. Estourgie SH, Nieweg OE, Valdés Olmos RA, et al. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003; 10: 681-688. (Pubitemid 40486901)
26. Doting MH, Hoekstra HJ, Plukker JT, et al. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol 2002; 28: 673-678.
27. Savoia P, Fava P, Nardò T, et al. Skin metastases of malignant melanoma: a clinical and prognostic survey. Melanoma Res 2009; 19: 321-326.
28. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16: 2253-2260. (Pubitemid 28265065)
29. Karimipour DJ, Lowe L, Lyndon S, et al. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful? J Am Acad Dermatol 2004; 50: 759-764. (Pubitemid 38580556)
30. Amersi F, Morton DL,. The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg 2007; 41: 241-256.